Advertisement
Research Article| Volume 33, ISSUE 5, P647-658, May 1992

Download started.

Ok

Low density lipoprotein from humans supplemented with n-3 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells.

Open AccessPublished:May 01, 1992DOI:https://doi.org/10.1016/S0022-2275(20)41429-4
Low density lipoprotein from humans supplemented with n-3 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells.
Previous ArticleSolubility of calcium salts of unconjugated and conjugated natural bile acids.
Next ArticleBile acid synthesis. VI. Regulation of cholesterol 7 alpha-hydroxylase by taurocholate and mevalonate.
      This paper is only available as a PDF. To read, Please Download here.
      Fish oil supplementation in humans is often associated with an expanded low density lipoprotein (LDL) pool that is not thought to reflect increased production. Since data on clearance of LDL after fish oil supplementation (FO-LDL) are equivocal, normal volunteers (four men and three women) received ten capsules containing 3.6 g eicosapentaenoic acid and 2.9 g docosahexaenoic acid (approximately 2.5% total calories as methyl esters) for 2 weeks. Total plasma cholesterol was unchanged, but triglycerides decreased 30%. Low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) were unchanged. Analysis of the LDL particles revealed that increased esterified cholesterol caused the FO-LDL core/surface ratio to be greater than baseline LDL (BL-LDL), resulting in a shift in mean LDL density from 1.060 to 1.056. N-3 fatty acids in FO-LDL were also increased greater than 40% at the expense of n-6 and n-9 fatty acids. Human hepatoma HepG2 cells were used to study the effects of FO-LDL on LDL receptor activity and mRNA abundance for the LDL receptor, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, and various apolipoproteins associated with cholesterol metabolism. In this system FO-LDL reduced LDL receptor activity compared to BL-LDL. Scatchard analysis revealed that LDL receptor number (Bmax) was reduced to one-third normal (P less than 0.001) whereas particle binding affinity was unchanged. The mRNA abundance for the LDL receptor and apoA-I were also depressed, even by low concentrations (10 micrograms/ml and 20 micrograms/ml LDL protein) of FO-LDL as compared to BL-LDL. HepG2 cells incubated with FO-LDL had decreased cellular free cholesterol but increased cholesteryl esters. Thus, moderate supplementation with fish oil n-3 fatty acids in normal humans enriches their LDL particles in cholesteryl esters and n-3 fatty acids. These particles depress both LDL receptor activity and LDL receptor mRNA abundance in HepG2 cells.

      REFERENCES

        • Goodnight S.H.
        • Harris W.S.
        • Connor W.E.
        • Illingworth D.R.
        Polyunsaturated fatty acids, hyperlipide-mia, and thrombosis.
        Arteriosclerosis. 1982; 2: 87-113
        • Nestel P.J.
        • Connor W.E.
        • Reardon M.F.
        • Connor S.
        • Wong S.
        • Boston R.
        Suppression by diets rich in fish oil of very low density lipoprotein production in man.
        J. Clin. Invest. 1984; 74: 82-89
        • Phillipson B.E.
        • Rothroick D.W.
        • Connor W.E.
        • Harris W.S.
        • Illingworth D.R.
        Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglyceridemia.
        N. Engl. J. Med. 1985; 312: 1210-1216
        • Harris W.S.
        • Connor W.E.
        • Inkeles S.B.
        • Illingworth D.R.
        Dietary omega-3 fatty acids prevent carbohydrate-induced hypertriglceridemia.
        Metabolism. 1984; 33: 1016-1019
        • Leaf A.
        • Weber P.C.
        Cardiovascular effects of n-3 fatty acids.
        N. Engl. J. Med. 1988; 318: 549-557
        • Sullivan D.R.
        • Sanders T.A.B.
        • Trayner I.M.
        • Thompson G.R.
        Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridaemic patients and normal subjects ingesting fish oil.
        Atherosclerosis. 1986; 61: 129-134
        • Daggy B.
        • Arost C.
        • Bensadoun A.
        Dietary fish oil decreases VLDL production rates.
        Biochim. Biophys. Acta. 1987; 920: 293-300
        • Demke D.M.
        • Peters G.R.
        • Linet O.I.
        • Metzler C.M.
        • Klott K.A.
        Effects of a fish oil concentrate in patients with hypercholesterolemia.
        Atherosclerosis. 1988; 70: 73-80
        • Harris W.S.
        • Connor W.E.
        • Illingworth D.R.
        • Rothrock D.W.
        • Foster D.M.
        Effects of fish oil on VLDL triglyceride kinetics in humans.
        J. Lipid Res. 1990; 31: 1549-1558
        • Illingworth D.R.
        • Harris W.S.
        • Connor W.E.
        Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans.
        Arteriosclerosis. 1984; 4: 270-275
        • Huff M.W
        • Telford D.E.
        Dietary fish oil increases conversion of very low density lipoprotein apoprotein B to low density lipoprotein.
        Arteriosclerosis. 1989; 9: 58-66
        • Wong S.
        • Nestel P.J.
        Eicosapentaenoic acid inhibits the secretion of triacylglycerol and of apoprotein B and the binding of LDL in HepG2 cells.
        Atherosclerosis. 1987; 64: 139-146
        • Roach R.D
        • Kambouris A.
        • Topping D.L.
        • Trimble R.P.
        • Nestel P.J.
        The effects of dietary fish oil on hepatic high density and low density lipoprotein receptor activities in the rat.
        FEBS Lett. 1987; 222: 159-162
        • Takagi K.
        • Alvarez J.G.
        • Favata M.F.
        • Trzaskos J.M.
        • Strauss III, J.F.
        Control of low density lipoprotein receptor gene promoter activity. Ketoconazole inhibits serum lipoprotein but not oxysterol suppression of gene transcription.
        J. Biol. Chem. 1989; 264: 12352-12357
        • Harris W.S.
        Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review.
        J. Lipid Res. 1989; 30: 785-807
        • Harris W.S.
        • Zucker M.L.
        • Dujovne C.A.
        ω-3 Fatty acids in hypertriglyceridemic patients: triglycerides vs methyl esters.
        Am. J. Clin. Nutr. 1988; 48: 992-997
        • Edelstein C
        • Scanu A.M.
        Precautionary measures for collecting blood destined for lipoprotein isolation.
        Methods Enzymol. 1986; 128: 151-155
        • Schumaker V.N.
        • Puppione D.L.
        Sequential flotation ultracentrifuges.
        Methods Enzymol. 1986; 128: 155-170
        • Havel R.J.
        • Eder H.A.
        • Bragdon J.H.
        The distribution and chemical composition of ultracentrifugally separated lipoprotein in human serum.
        J. Clin. Invest. 1955; 34: 1345-1353
        • Lowry O.H.
        • Rosebrough N.J.
        • Farr A.L.
        • Randall R.J.
        Protein measurement with the Folin phenol reagent.
        J. Biol. Chem. 1951; 193: 265-275
        • Terpstra A.H.M.
        • Beynen A.C.
        Density profile and cholesterol concentration of serum lipoproteins in experimental animals and human subjects on hyper-cholesterolaemic diets.
        Biochem. Physiol. 1984; 77B: 523-528
        • Terpstra A.H.M.
        • Woodward C.J.H.
        • Sanchez-Muniz F.J.
        Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: visualization by prestaining and rapid separation of serum lipoproteins from same volumes of serum.
        Anal. Biochem. 1981; 111: 149-157
        • Contreras M.A.
        • Bale W.F.
        • Spar I.L.
        Iodine monochloride iodination techniques.
        Methods Enzymol. 1983; 92: 277-292
        • Bilheimer D.W.
        • Eisenberg S.
        • Levy R.I.
        The metabolism of very low density lipoproteins.
        Biochim. Biophys. Acta. 1972; 260: 212-221
        • Fidge N.H.
        • Poulis P.
        Studies on the radioiodi-nation of very low density lipoprotein obtained from different mammalian species.
        Clin. Chim. Acta. 1974; 52: 15-26
        • Friedwald W.T
        • Levy R.I.
        • Fredrickson D.S.
        Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracen-trifuge.
        Clin. Chem. 1972; 18: 499-502
        • Bieri J.G.
        • Tolliver T.J.
        • Catignani G.L.
        Simultaneous determination of a-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography.
        Am. J. Clin. Nutr. 1979; 32: 2143-2149
        • Lepage G.
        • Roy C.C.
        Direct transesterification of all classes of lipids in one-step reaction.
        J. Lipid Res. 1986; 27: 114-120
        • Kim J.C
        • Chung T.H.
        Direct determination of the free cholesterol and individual cholesteryl esters in serum by high pressure liquid chromatography.
        Korean J. Biochem. 1984; 16: 69-77
        • Brown W.V
        • Levy R.I.
        • Fredrickson D.S.
        Studies of the proteins in human very low density lipoprotein.
        J. Biol. Chem. 1969; 244: 5687-5694
        • Laemmli U.K.
        Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
        Nature. 1970; 227: 680-685
        • Goldstein J.L.
        • Brown M.S.
        Binding-and degradation of low density lipoprotein by cultured human fibroblasts.
        J. Biol. Chem. 1974; 249: 5153-5162
        • Lindsey S.
        • Benattar J.
        • Pronczuk A.
        • Hayes K.C.
        Dietary palmitic acid (16:0) enhances high density lipoprotein cholesterol and low density lipoprotein receptor mRNA abundance in hamsters.
        Proc. Exp. Biol. Med. 1990; 195: 261-269
        • Inagaki M.
        • Harris W.S.
        Changes in lipoprotein composition in hypercholesterolemic patients taking cholesterol-free fish oil supplements.
        Atherosclerosis. 1990; 82: 237-246
        • Pronczuk A.
        • Kipervarg Y.
        • Hayes K.C.
        Vegetarians have higher plasma alpha-tocopherol relative to cholesterol than nonvegetarians..
        J. Am. Coll. Nutr. 1992; 11: 50-55
        • Brown M.S.
        • Goldstein J.L.
        Regulation of the activity of the low density lipoprotein receptor in human fibroblasts.
        Cell. 1975; 6: 307-316
        • Saucier S.E.
        • Kandutsch A.A.
        • Gayen A.K.
        • Kwahn D.K.
        • Spencer T.A.
        Oxysterol regulation of 3-hydroxy-3-methylglutaryl-CoA reductase in liver. Effect of dietary cholesterol.
        J. Biol. Chem. 1989; 264: 6863-6869
        • Ventura M.A.
        • Woollett L.A.
        • Spady D.K.
        Dietary fish oil stimulates hepatic low density lipoprotein transport in the rat.
        J. Clin. Invest. 1989; 84: 528-537
        • Johnson M.R.
        • Mathur S.N.
        • Coffman C.
        • Spector A.A.
        Dietary fat saturation and hepatic acylcoen-zyme Axholesterol acyltransferase activity. Effect of n-3 polyunsaturated and long-chain saturated fat.
        Arteriosclerosis. 1983; 3: 242-248
        • Field F.J.
        • Albright E.J.
        • Mathur S.N.
        Effect of dietary n-3 fatty acids on HMG-CoA reductase and ACAT activities in liver and intestine of the rabbit.
        J. Lipid Res. 1987; 28: 50-58
        • Spector A.A.
        • Kaduce T.L.
        • Dane R.W.
        Effect of dietary fat saturation on acylcoenzyme Axholesterol acyltransferase activity of rat liver microsomes.
        J. Lipid Res. 1980; 21: 169-179
        • Jones P.J.H.
        • Ridgen J.E.
        • Benson A.P.
        Influence of dietary fatty acid composition on cholesterol synthesis and esterification in hamsters.
        Lipids. 1990; 25: 815-820
        • Parks J.S.
        • Wilson M.D.
        • Johnson F.L.
        • Rudel L.L.
        Fish oil decreases hepatic cholesteryl ester secretion but not apoB secretion in African green monkeys.
        J. Lipid Res. 1989; 30: 1535-1544
        • Stenson W.F
        • Seetharam B.
        • Talkad V.
        • Pickett W.
        • Dudeja P.
        • Brasitus T.A.
        Effects of dietary fish oil supplementation on membrane fluidity and enzyme activity in rat small intestine.
        Biochem. J. 1989; 263: 41-45
        • Loscalzo J.
        • Freedman J.
        • Rudd M.A.
        • Barsky-Vasserman I.
        • Vaughan D.E.
        Unsaturated fatty acids enhance low density lipoprotein uptake and degradation by peripheral blood mononuclear cells.
        Arteriosclerosis. 1987; 7: 450-455
        • Salem Jr., N.
        • Kim H.Y.
        • Yergey J.A.
        Docosa-hexaenoic acid: membrane function and metabolism.
        in: Simopoulos A.P. Kiefer R.R. Martin R.E. Health Effects of Polyunsaturated Fatty Acids in Seafoods. Academic Press, Inc., Florida1986: 263-317
        • St. Clair R.W.
        • Leight M.A.
        Differential effects of isolated lipoproteins from normal and hypercholesterolemic rhesus monkeys on cholesterol esterification and accumulation in arterial smooth muscle cells in culture.
        Biochim. Biophys. Acta. 1978; 530: 279-291
        • Molowa D.T.
        • Cimis G.M.
        Co-ordinate regulation of low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase and synthase gene expression in HepG2 cells.
        Biochem. J. 1989; 260: 731-736
        • Hayes K.C
        • Lindsey S.
        • Pronczuk A.
        • Dobbs S.
        Dietary 18:1/18:2 ratio correlates highly with hepatic FC and mRNAs for apoA-I, apoE, and the LDL receptor.
        Arteriosclerosis. 1988; 8 (Abstr): 565a
        • Lindsey S.
        • Ross J.
        • Hayes K.C.
        Fed-fasting modulates LDL receptor and apolipoprotein mRNA abundance in hamsters fed high- or low-fat diets.
        Arteriosclerosis. 1990; 10 (Abstr.): 884a
        • Beynen A.C
        • Scholz K.E.
        • Van Zutphen L.F.M.
        • West C.E.
        Correlation between the cholesterolemic responses produced by dietary cholesterol and casein in rabbits.
        J. Nutr. 1983; 113: 1204-1211
        • Rudel L.L.
        • Pitts II, L.L.
        • Nelson C.A.
        Characterization of plasma low density lipoproteins of non-human primates fed dietary cholesterol.
        J. Lipid Res. 1977; 18: 211-222
        • Ohtani H.
        • Hayashi K.
        • Hirata Y.
        • Dojo S.
        • Naka-shima K.
        • Nishio E.
        • Kurushima H.
        • Saeki M.
        • Kajiyama G.
        Effects of dietary cholesterol and fatty acids on plasma cholesterol level and hepatic lipoprotein metabolism.
        J. Lipid Res. 1990; 31: 1413-1422
        • Berns M.A.M.
        • deVries J.H.M.
        • Katan M.B.
        Increases in body fatness as a major determinant of changes in serum total cholesterol and HDL in young men over a ten year period.
        Am. J. Epidemiol. 1989; 130: 1109-1122
        • Bradley D.D
        • Wingerd J.
        • Petitti D.B.
        • Krauss R.M.
        • Ramcharan S.
        Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens, and progestins.
        N. Engl. J. Med. 1978; 299: 17-20
        • Bard J.M.
        • Parra H.J.
        • Douste-Blazy P.
        • Fruchart J.C.
        Effect of pravastatin, an HMG-CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
        Metabolism. 1990; 39: 269-273
        • Seishima M.
        • Bisgaier C.L.
        • Davies S.L.
        • Glickman R.M.
        Regulation of hepatic apolipoprotein synthesis in the 17α-ethinyl estradiol-treated rat.
        J. Lipid Res. 1991; 32: 941-951
        • Wong S-H.
        • Fisher E.A.
        • Marsh J.B.
        Effects of eicosapentaenoic and docosahexaenoic acids on apoprotein B mRNA and secretion of very low density lipoproteins in HepG2 cells.
        Arteriosclerosis. 1989; 9: 836-841

      Article info

      Publication history

      Published online: May 01, 1992

      Identification

      DOI: https://doi.org/10.1016/S0022-2275(20)41429-4

      Copyright

      © 1992 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.

      User license

      Creative Commons Attribution (CC BY 4.0) |
      How you can reuse Information Icon
      Creative Commons Attribution (CC BY 4.0)

      Permitted

      • Read, print & download
      • Redistribute or republish the final article
      • Text & data mine
      • Translate the article
      • Reuse portions or extracts from the article in other works
      • Sell or re-use for commercial purposes

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect

      ASBMB  ASBMB  ASBMB  ASBMB

      ISSN 0022-2275
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX